han172189 wrote:
現在是科學時代,講究(恕刪)
抱歉啦,
其他1450都嘴巴喊高端伸手打別家的,
只有個案能提供啦。
tpman77 wrote:
可怕!打mRNA 的BNT...(恕刪)
Reliable research shows this is simply the reaction expected from a vaccine: a high immune response without a systemic and uncontrolled inflammation. Furthermore, arguing that SARS-CoV-2 vaccination would result in loss of the Type I IFN immune response (and therefore leading to a higher infectious risk or lack of cancer surveillance) contradicts other published data on the immune response. At the opposite, a transient increase of Type I IFN could explain some immune side effects caused by vaccination. To date only a set of SARS-COV-2 viral proteins have been shown to antagonize Type I IFN response, not the vaccine.
症狀
症狀為高燒、紅腫、腫脹、極度疲倦與噁心。在某些情況下可能致命。
SARS-CoV-2 病毒藉由與 ACE2 受器結合而進入人體細胞,免疫系統的病原相關分子模式(PAMPs)在識別病毒核酸後,會啟動多重免疫途徑(NF-κB/TNFα 途徑、IL-6/JAK/STAT 途徑、S1PR1(1-磷酸鞘氨醇受體1)途徑),進而刺激細胞因子分泌及 CD4 T細胞分化。由於 COVID-19 患者血清 IL-6 明顯上升,且可能與急性呼吸窘迫症候群相關,托珠單抗(tocilizumab,IL-6R單抗)已於2021年6月在美國獲得了用於治療嚴重特殊傳染性肺炎的緊急使用授權[9]。
The misuse and the erroneous interpretations which can result from the VAERS (Vaccine Adverse Events Database) database has been extensively described. Besides, the analysis proposed by the authors only takes into account the relative values of the occurrences of several adverse events for SARS-COV-2 or non- SARS-COV-2 vaccines without taking into account either the number of injections for each vaccine or the differences in pharmacovigilance.